Other
Targeted biopsy
Targeted biopsy is an intervention with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
completed267%
active_not_recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
active_not_recruiting
Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate Biopsy
NCT05761912
completed
Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer
NCT02425228
completednot_applicable
Use of Multi-Parametric MRI With Prostate Biopsy for Cancer Diagnosis.
NCT01964638
Clinical Trials (3)
Showing 3 of 3 trials
NCT05761912
Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate Biopsy
NCT02425228
Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer
NCT01964638Not Applicable
Use of Multi-Parametric MRI With Prostate Biopsy for Cancer Diagnosis.
All 3 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 3